FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of

FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of

Filed under: Washington D.C. Drug Rehab Centers

Washington, DC – To Protect Competition, Companies Agree to Sell Rights and Assets to 18 Drugs to Sandoz and Par, Relinquish Manufacturing and Marketing Rights for Three Other Drugs: The Federal Trade Commission will require Watson Pharmaceuticals, Inc …
Read more on Imperial Valley News

 

The Cost of Dying: Simple act of feeding poses painful choices

Filed under: Washington D.C. Drug Rehab Centers

Anti-cancer drugs costing tens of thousands of dollars that extend life for mere months with deeply sickening side effects? The cost of … "It is amazing how long you can keep someone alive," said Dr. Leslie Foote, medical director of the Salinas …
Read more on San Jose Mercury News

 

Immunomedics' CEO Discusses F1Q13 Results – Earnings Call Transcript

Filed under: Washington D.C. Drug Rehab Centers

At the American College of Rheumatology Annual Scientific Meeting, which opens today in Washington DC. Lupus investigators will report results from an open labeled single arm extension study in patients with moderately to severely active lupus, who …
Read more on Seeking Alpha